Furthermore, the increased survival conferred by anti-PD-L1 therapy (Fig. 2e) suggests an essential role of T cells in mediating anti-tumor effects, though this effect is likely enabled by the continued dosing of the antibody beyond the neuralization of acute immunosuppression. This evidence concerns the gene CD274 and neoplasm.